Observational study on the prognostic value of testosterone and adiposity in postmenopausal estrogen receptor positive breast cancer patients

被引：0
|
作者：
Elisabetta Venturelli
Annalisa Orenti
Aline S. C. Fabricio
Giulia Garrone
Roberto Agresti
Biagio Paolini
Chiara Bonini
Massimo Gion
Franco Berrino
Christine Desmedt
Danila Coradini
Elia Biganzoli
机构：
[1] Department of Research,Department of Diagnostic Pathology and Laboratory
[2] Fondazione IRCCS Istituto Nazionale dei Tumori,Breast Cancer Translational Research Laboratory, J. C. Heuson, Institut Jules Bordet
[3] Laboratory of Medical Statistics and Epidemiology,Unit of Medical Statistics, Biometry and Bioinformatics
[4] “Giulio A. Maccacaro”,undefined
[5] Department of Clinical Sciences and Community Health,undefined
[6] Regional Center for Biomarkers,undefined
[7] Department of Clinical Pathology and Transfusion Medicine,undefined
[8] Breast Surgery Unit,undefined
[9] Fondazione IRCCS Istituto Nazionale dei Tumori,undefined
[10] Fondazione IRCCS Istituto Nazionale dei Tumori,undefined
[11] Université Libre de Bruxelles,undefined
[12] Campus Cascina Rosa,undefined
[13] Fondazione IRCCS Istituto Nazionale Tumori,undefined
来源：
BMC Cancer | / 18卷
关键词：
Testosterone; Body mass index; Estrogen receptor; Postmenopausal women; Breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Complete estrogen blockade in advanced postmenopausal receptor-positive breast cancer
    Nature Clinical Practice Oncology, 2008, 5 (2): : 67 - 67
  • [22] Prognostic effects of gene mutation in estrogen receptor positive breast cancer
    Griffith, Obi L.
    Griffith, Malachi
    Luo, Jingqin
    Hundall, Jasreet
    Miller, Christopher A.
    Larson, David E.
    Fulton, Robert
    Wilson, Richard K.
    Liu, Shuzhen
    Leung, Samuel
    Nielsen, Torsten O.
    Mardis, Elaine R.
    Ellis, Matthew J.
    CANCER RESEARCH, 2015, 75
  • [23] Region-specific glucocorticoid receptor promoter methylation has both positive and negative prognostic value in patients with estrogen receptor-positive breast cancer
    Hilary Snider
    Brithica Villavarajan
    Yingwei Peng
    Lois E. Shepherd
    Andrew C. Robinson
    Christopher R. Mueller
    Clinical Epigenetics, 2019, 11
  • [24] Region-specific glucocorticoid receptor promoter methylation has both positive and negative prognostic value in patients with estrogen receptor-positive breast cancer
    Snider, Hilary
    Villavarajan, Brithica
    Peng, Yingwei
    Shepherd, Lois E.
    Robinson, Andrew C.
    Mueller, Christopher R.
    CLINICAL EPIGENETICS, 2019, 11 (01)
  • [25] Prognostic value of the 21-gene recurrence score for regional recurrence in patients with estrogen receptor-positive breast cancer
    Koh, Minji
    Jung, Jinhong
    Kim, Su Ssan
    Do Ahn, Seung
    Choi, Eun Kyung
    Chung, Il Yong
    Lee, Jong Won
    Kim, Sung-Bae
    Jeong, Jae Ho
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 188 (03) : 583 - 592
  • [26] Prognostic value of the 21-gene recurrence score for regional recurrence in patients with estrogen receptor-positive breast cancer
    Minji Koh
    Jinhong Jung
    Su Ssan Kim
    Seung Do Ahn
    Eun Kyung Choi
    Il Yong Chung
    Jong Won Lee
    Sung-Bae Kim
    Jae Ho Jeong
    Breast Cancer Research and Treatment, 2021, 188 : 583 - 592
  • [27] Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1-98
    Kensler, Kevin H.
    Regan, Meredith M.
    Heng, Yujing J.
    Baker, Gabrielle M.
    Pyle, Michael E.
    Schnitt, Stuart J.
    Hazra, Aditi
    Kammler, Roswitha
    Thurlimann, Beat
    Colleoni, Marco
    Viale, Giuseppe
    Brown, Myles
    Tamimi, Rulla M.
    BREAST CANCER RESEARCH, 2019, 21 (1)
  • [28] Abiraterone acetate, exemestane or the combination in postmenopausal patients with estrogen receptor-positive metastatic breast cancer
    O'Shaughnessy, J.
    Campone, M.
    Brain, E.
    Neven, P.
    Hayes, D.
    Bondarenko, I.
    Griffin, T. W.
    Martin, J.
    De Porre, P.
    Kheoh, T.
    Yu, M. K.
    Peng, W.
    Johnston, S.
    ANNALS OF ONCOLOGY, 2016, 27 (01) : 106 - 113
  • [29] Prognostic and predictive value of low estrogen receptor expression in breast cancer
    Bouchard-Fortier, A.
    Provencher, L.
    Blanchette, C.
    Diorio, C.
    CURRENT ONCOLOGY, 2017, 24 (02) : E106 - E114
  • [30] PROGNOSTIC VALUE OF ESTROGEN-RECEPTOR TO ENDOCRINE ABLATION IN CANCER OF BREAST
    LEUNG, BS
    KRIPPAEHNE, WW
    FLETCHER, WS
    SURGERY GYNECOLOGY & OBSTETRICS, 1974, 139 (04): : 525 - 528
12345